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Introduction: The inherent low oxygen tension in normal cartilage has implications on inflammatory conditions
associated with osteoarthritis (OA). Biomechanical signals will additionally contribute to changes in tissue
remodelling and influence the inflammatory response. In this study, we investigated the combined effects of
oxygen tension and fibronectin fragment (FN-f) on the inflammatory response of chondrocytes subjected to
biomechanical signals.
Methods: Chondrocytes were cultured under free-swelling conditions at 1%, 5% and 21% oxygen tension or
subjected to dynamic compression in an ex vivo 3D/bioreactor model with 29 kDa FN-f, interleukin-1beta (IL-1β)
and/or the nitric oxide synthase (NOS) inhibitor for 6 and 48 hours. Markers for catabolic activity (NO, PGE2), tissue
remodelling (GAG, MMPs) and cytokines (IL-1β, IL-6 and TNFα) were quantified by biochemical assay. Aggrecan,
collagen type II, iNOS and COX-2 gene expression were examined by real-time quantitative PCR. Two-way ANOVA
and a post hoc Bonferroni-corrected t-test were used to analyse data.
Results: Both FN-fs and IL-1β increased NO, PGE2 and MMP production (all P < 0.001). FN-f was more active than
IL-1β with greater levels of NO observed at 5% than 1% or 21% oxygen tension (P < 0.001). Whilst FN-f reduced
GAG synthesis at all oxygen tension, the effect of IL-1β was significant at 1% oxygen tension. In unstrained
constructs, treatment with FN-f or IL-1β increased iNOS and COX-2 expression and reduced aggrecan and collagen
type II (all P < 0.001). In unstrained constructs, FN-f was more effective than IL-1β at 5% oxygen tension and
increased production of NO, PGE2, MMP, IL-1β, IL-6 and TNFα. At 5% and 21% oxygen tension, co-stimulation with
compression and the NOS inhibitor abolished fragment or cytokine-induced catabolic activities and restored
anabolic response.
Conclusions: The present findings revealed that FN-fs are more potent than IL-1β in exerting catabolic effects
dependent on oxygen tension via iNOS and COX-2 upregulation. Stimulation with biomechanical signals abolished
catabolic activities in an oxygen-independent manner and NOS inhibitors supported loading-induced recovery
resulting in reparative activities. Future investigations will utilize the ex vivo model as a tool to identify key targets
and therapeutics for OA treatments.* Correspondence: t.t.chowdhury@qmul.ac.uk
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Animal and in vitro studies have provided convincing
evidence for a role of matrix degradation products in
regulating cartilage homeostasis and driving osteoarthritis
(OA) disease progression [1-3]. In chondrocytes, frag-
ments derived from fibronectin initiate both catabolic and
anabolic signalling cascades in a concentration-dependent
manner [3,4]. At low concentration, fragments augment
anabolic processes and facilitate reparative processes when
the extracellular matrix is damaged. However, if fragment
levels increase above a certain threshold, the pathways
switch from anabolic to catabolic and accelerate matrix
damage mediated by production of matrix metallopro-
teinases (MMPs) and cytokines [2]. The importance of
fragment-induced damaging effects were highlighted in
previous clinical studies, which reported elevated levels of
fibronectin fragments (FN-fs) in osteoarthritic or rheuma-
toid cartilage and OA synovial fluids [5-8]. The catabolic
environment up-regulates tissue remodelling but the re-
sponse will be influenced by mechanical factors which
interfere with the pathways [9,10]. The mediators that ini-
tiate the early phase of matrix damage are therefore com-
plex and involve both mechanical and biological factors.
In addition, the way in which biomechanical signals
modulate fragment-induced mechanisms for repair and/or
degradation in early stage OA are unclear and require fur-
ther investigation.
Indeed, the amino-terminal FN-f has been shown to
have potent catabolic activities leading to enhanced
levels of nitric oxide (NO), prostaglandin E2 (PGE2) and
MMPs in human or bovine cells cultured in 3D agarose,
monolayer or explant models [1,3,11-13]. The signalling
pathways involve the mitogen activated protein kinase
(MAPK) and nuclear factor-kappa B (NFκB) cascades
mediated by stimulation of integrin receptors, leading to
suppression of proteoglycan synthesis and increased
proteoglycan depletion [14,15]. Furthermore, inducible
nitric oxide synthase (iNOS) inhibitors have been shown
to reduce the catabolic effect in cartilage explants
treated with FN-f and repair damaged tissue by facilitat-
ing anabolic processes [12]. Recently, we showed that
intermittent compression applied in a dynamic manner
inhibits FN-f induced NO and PGE2 production and re-
stores matrix synthesis in chondrocytes cultured in agar-
ose constructs [16]. In this study, treatment with iNOS
inhibitors and stimulation with mechanical signals was
shown to prevent FN-f-induced catabolic response. In
addition, fibronectin concentrations were demonstrated
to increase by cyclic impact load and alter matrix synthe-
sis in cartilage explants [17]. Mechanical loading condi-
tions that mimic injury and overloading may accelerate
mild damage with an early rebuilding phase by increasing
MMPs, matrix fragment levels and metabolic activity [18].
However, the response will at least, in part, be dependenton the type of mechanical loading regime, its duration and
whether loading was applied during the early or late stage
of the disease process. It is, therefore, plausible that
physiological mechanical signals compete with the cata-
bolic pathways induced by the matrix fragments and con-
tribute to early reparative signals.
Furthermore, the oxygen tension of cartilage will influ-
ence the response of chondrocytes to inflammatory
factors and biomechanical signals. In OA, the tissue is
more hypoxic than normal cartilage with pathophysio-
logical levels less than 5% leading to increased production
of NO and PGE2 release in tissues involving the cartilage
and meniscus [19-21]. The interactions of inflammatory
mediators, such as interleukin-1β (IL-1β), with oxygen
tension has detrimental effects on matrix turnover, which,
in turn, affects the ability of the cells to respond to mech-
anical loading, possibly through the disruption of normal
integrin-based signals [19-21]. Given the potential inflam-
matory effects of hypoxia on cell metabolism, it is highly
likely that oxygen tension will affect the response of chon-
drocytes to both matrix fragments and mechanical stimuli.
However, to date, no research groups have examined the
combined effect of fragments, oxygen tension and bio-
mechanical signals in chondrocytes. The present study,
therefore, investigated the effects of oxygen tension and
FN-f on catabolic and anabolic activities in chondrocyte/
agarose constructs subjected to dynamic compression and
compared the response to constructs treated with IL-1β.
Methods
Chondrocyte isolation and culture in agarose constructs
This study involves bovine cells procured from a local
abbatoir with authorization from the relevant meat inspec-
tors (Dawn Cardington, Bedfordshire, UK). It does not
involve humans, human tissue or experimentation on ani-
mals. Cartilage explants were obtained from the metacar-
palphalangeal joints of 18-month-old cattle and diced, as
previously described [22,23]. The tissue was incubated on
rollers for 1 h at 37°C in Dulbecco’s Modified Eagle’s
Medium supplemented with 20% (v/v) foetal calf serum
(DMEM+ 20% FCS), 2 μM L-glutamine, 5 μg/ml penicillin,
5 μg/ml streptomycin, 20 mM Hepes buffer, and
0.85 μM L-ascorbic acid in addition to 700 unit/ml pronase,
and for a further 16 h at 37°C in medium supplemented
with 100 unit/ml collagenase type XI (All from Sigma-
Aldrich Ltd, Gillingham, Dorset, UK). The chondrocyte
suspension was washed and the cells counted using a
haemocytometer. Cell viability was calculated with the
trypan blue exclusion assay and resuspended in medium
at a concentration of 8 × 106 cells/ml. The cell suspension
was added to an equal volume of molten 6% (w/v) agarose
type VII in Earle’s Balanced Salt Solutions (EBSS) to yield
a final cell concentration of 4 × 106 cells/ml in 3% (w/v)
agarose (Sigma-Aldrich Ltd, Gillingham, Dorset, UK). The
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less steel mould, containing holes, 5 mm in diameter and
5 mm in height, and allowed to gel at 4°C for 10 minutes.
Constructs were transferred into wells of a 24-well culture
plate and immediately subjected to ex vivo conditions.
Effects of oxygen tension and FN-f in chondrocyte/
agarose constructs
The effects of 1, 5 and 21% oxygen tension were examined
in constructs cultured under free-swelling conditions in a
glove-box style workspace integrated with the Biospherix
Ltd, Lacona, NY, USA incubator to ensure that the experi-
mental conditions during set-up were uninterrupted
(Figure 1). 1 ml DMEM+ 20% FCS was supplemented
with 0 or 1 μm of 29 kDa NH2-heparin-binding FN-f
(generous gift from Prof Gene Homandberg) and/or
1 mM of L-N-(1-iminoethyl)-ornithine (L-NIO). This
agent inhibits all isoforms of the nitric oxide synthase
enzymes (Merck Chemicals, Nottingham, UK) for 48 hr.
FN-fs were isolated from cathepsin D and thrombin di-
gests of fibronectin from plasma adsorption, as previously
described [24]. In addition, the FN-f-induced response
was compared to constructs treated with 0 or 10 ng/ml
IL-1β (Peprotech EC Ltd, London, UK) and/or L-NIO at
1, 5 and 21% oxygen tension. The ex vivo conditions are
summarized in Figure 2.
Application of dynamic compression
In separate experiments, a novel ex vivo bioreactor (Bose
ElectroForce, Gillingham, UK) was used to apply dy-
namic compression to constructs cultured at 5 or 21%
oxygen tension (Figure 1). Constructs were transferred
into individual wells of a 24-well culture plate (Figure 1A,
inset) and mounted within the bioreactor device that was
integrated with the Biospherix incubator (Figure 1B, C).
The medium was supplemented with either 0 or 1 μM
FN-f or 10 ng/ml IL-1β and/or 1 mM L-NIO and the ex-
perimental conditions during set-up were uninterrupted.A B 
Figure 1 The ex vivo system. Bose bioreactor (A) integrated with the Bio
controlled oxygen tension within the incubator (C). The inset in (A) shows
positioned above a 24-well culture plate.Constructs were subjected to intermittent compression
under unconfined conditions, with a profile of 10 minutes
compression followed by a 5- hour 50-minute unstrained
period for both the 6- and 48-hour culture periods, as pre-
viously described [16,25]. The compression regime was
applied in a dynamic manner with strain amplitude of
0 to 15% in a sinusoidal waveform at a frequency of 1 Hz
and resulted in duty cycles which ranged from 600 to
4,800 cycles. Control constructs were unstrained, but were
maintained within the ex vivo bioreactor. The ex vivo con-
ditions are summarized in Figure 2 and the 48-hour time
point was found to be optimal when measuring produc-
tion of inflammatory mediators and GAG synthesis.
Biochemical analysis
At the end of the 48-hour experiment, the constructs and
corresponding media were removed and stored at −20°C
prior to analysis. Constructs were digested overnight with
2.8 unit.ml−1 papain and 10 unit/ml agarase at 37°C (both
Sigma-Aldrich Ltd, Gillingham, Dorset, UK), as previously
described [22,26]. Media samples were analysed for total
MMP activity using a fluorogenic substrate assay. A 20-μl
sample was mixed with 10 μM Dnp-PChaGCHAK(Nma)
fluorogenic MMP substrate in 50 μl buffer (50 mM
HEPES, 10 mM CaCl2, 10 μM ZnCl2, 0.05% Brij-35,
pH 7.0) in each well of a 96-well plate (Enzo Life Sciences,
Exeter, UK). Reactions were measured by fluorescence
at excitation and emission values of 340 and 440 nm, re-
spectively. TNF-α (Bethyl Laboratories Inc., Montgomery,
AL, USA), IL-1β and IL-6 (both from Thermo Scientific,
Cramlington, Northumberland, UK) were quantified by
ELISA according to manufacturers’ instructions. Absolute
concentrations of nitrite (μM), a stable end-product of NO,
were measured in the culture media using a spectrophoto-
metric method based on the Griess assay. PGE2 production
was measured in the culture media by EIA (R&D Systems,
Abingdon, Oxfordshire, UK). Total DNA was determined
from agarase/papain digest using the Hoescht 33258C 
spherix (B) to facilitate uninterrupted ex vivo conditions, under
custom designed compressive mounting plate with loading pins
Gene expression 
Anabolic: aggrecan, 
col2A1. Catabolic:
iNOS, COX2 
(+/-) FN-f and/or L-NIO 
(+/-) IL-1  and/or L-NIO 
Ex-vivo 
free-swelling 
Ex-vivo 
bioreactor
1, 5 and 21% 
oxygen tension 
5 or 21% oxygen tension  
Dynamic compression 
(15%, 1Hz) 
(+/-) FN-f and/or L-NIO 
(+/-) IL-1  and/or L-NIO 
6 hr 48 hr 
NO/PGE2 release 
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Anabolic: GAG/DNA 
Catabolic: NO, MMPs, PGE2
Pro-inflammatory cytokine 
release: IL-1 , IL-6, TNF
Chondrocyte/agarose 
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48 hr 
Figure 2 Summary of the ex vivo test conditions and types of analysis. Chondrocyte/agarose constructs were cultured ex vivo under free-
swelling conditions (1, 5 and 21%) or subjected to dynamic compression (15%, 1 Hz) at 5 and 21% oxygen tension. At the end of the experiment,
constructs and/or media samples were analysed by biochemical assay or RNA was extracted from constructs, reverse transcribed and gene
expression quantified by RT-qPCR.
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media samples by DMB assay. These methods have been
previously detailed [22,26].
RNA isolation, reverse transcription and real-time
quantitative PCR
At the end of the six-hour bioreactor experiment, RNA was
isolated from chondrocytes cultured in agarose using the
QIAquick Spin gel extraction and RNeasy kit (Qiagen,
Crawley, West Sussex, UK), as previously described [27].
The six-hour time point was found to be optimal when
examining gene expression [25]. DNA-free DNase treatment
and removal reagents were used to eliminate any contamin-
ating DNA from the RNA sample (Applied Biosystems,
Warrington, UK). RNA was quantified on the Nanodrop
ND-1000 spectrophotometer (LabTech, Uckfield, East
Sussex, UK), and reverse transcription was performed with
Enhanced Avian RT First Strand cDNA synthesis kit, oligo
(dT)23 primer, and a total of 200 ng of RNA (Sigma-
Aldrich Ltd, Gillingham, Dorset, UK). Real-time quanti-
tative polymerase chain (qPCR) assays coupled with
Molecular Beacons were performed in 25-μl reaction
mixtures containing 1 μl cDNA, 12.5 μl JumpStart Taq
PCR Master Mix, primer pairs/probes with concentrations
detailed in Table 1 and nuclease-free PCR-grade water to
25 μl (Sigma Genosys, Cambridge, UK). Each sample was
run in duplicate on the 96-well thermal system of
the Mx3000P quantitative PCR instrument (Stratagene,
Amsterdam, Netherlands). Thermocycling conditions
comprised an initial polymerase activation step at 95°Cfor 10 minutes, followed by denaturation of 35 cycles at
95°C for 30 seconds, annealing at 55°C for 1 minute, and
extension at 72°C for 1 minute. The real-time PCR effi-
ciencies (E) of amplification for each target were defined ac-
cording to the relation, E = 10(−1/slope) and revealed
efficiency values ranging from 1.96 to 2.05.
Fluorescence data were collected during the annealing
stage of amplification, and data were analyzed on the
MxPro qPCR software (version 3, Agilent Technologies
Inc, Wokingham, Berkshire, UK). Baselines and thresholds
were automatically set by the RG-3000 qPCR software
and used after manual inspection. The cycle threshold
(Ct) value for each duplicate reaction was expressed as the
mean value, and the results were exported into Microsoft
Excel for further analysis. Relative quantification of colla-
gen type II, aggrecan, COX-2 and iNOS signals were
estimated by normalizing each target to the reference
gene, GAPDH, and to the calibrator sample (untreated,
unstrained condition) by a comparative Ct approach. For
each sample, the ratio of target ΔCt and reference ΔCt
was calculated, as previously described [27].
Statistics
For free-swelling studies, data represent the mean and SEM
values of 12 replicates from three separate experiments. For
the ex vivo/bioreactor experiments, biochemical and gene-
expression data represent the mean and SEM values
of up to 12 replicates from at least three separate
experiments. Statistical analysis was performed with
a two-way analysis of variance (ANOVA) and the
Table 1 Beacon designer sequences and real-time reaction efficiencies of qPCR assays
Gene Accession number Sequences nM Efficiency
iNOS U14640 Probe:5′-FAM-CGCGATCCCTGCTTGGTGGCGAAGATGAGCGATCGCG- 200
DABCYL-3′ 200 2.01
Forward: 5′-GTAACAAAGGAGATAGAAACAACAGG-3′ 200 (± 0.08)
Reverse: 5′-CAGCTCCGGGCGTCAAAG-3′
Probe: 5′-FAM-
COX-2 AF031698 CGCGATCGTCAGAAATTCGGGTGTGGTACAGTTGATCGCG-DABCYL-3′ 200
Forward: 5′-CGAGGTGTATGTATGAGTGTAGG-3′ 300 1.99
Reverse: 5′-GTTGGGAGTGGGTTTCAGG-3′= 300 (± 0.04)
Probe: 5′-FAM- 200
Aggrecan U76615 CGCGATCCACTCAGCGAGTTGTCAGGTTCTGAGATCGCG-DABCYL-3′ 2.05
Forward: 5′-TGGTGTTTGTGACTCTGAGG-3′ 100 (± 0.07)
Reverse: 5′-GATGAAGTAGCAGGGGATGG-3′ 200
Collagen type II X02420 Probe: 5′-FAM-CGCGATGCGTCAGGTCAGGTCAGCCATATCGCG-
DABCYL-3′ 200
Forward: 5′-AAACCCGAACCCAGAACC-3′ 100 1.96
Reverse: 5′-AAGTCCGAACTGTGAGAGG-3′ 100 (± 0.08)
GAPDH U85042 Probe: 5′-HEX-CGCGATCCACCATCTTCCAGGAGCGAGATCCGATCGCG-
DABCYL-3′ 200 1.96
Forward: 5′-TTCAACGGCACAGTCAAGG-3′ 200 (± 0.01)
Reverse: 5′-TTCAACGGCACAGTCAAGG-3′ 200
Note: Real-time reaction efficiencies of qPCR assays with optimal primer and probe concentrations are shown. Probes contain FAM or HEX as a 5′- reporter dye
and DABCYL as 3′- quencher with the arm sequences underlined.
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pare differences between the various treatment groups,
as indicated in the figure legend. For gene-expression data,
ratio values were log transformed before analysis by a
two-way ANOVA and a post hoc Bonferroni-corrected t
test. In all cases, a level of 5% was considered statistically
significant (P <0.05).
Results
FN-f maximally increased catabolic activities at 5%
oxygen tension
The ability of FN-f to influence the levels of NO, PGE2 and
GAG synthesis in an oxygen-dependent manner were
compared to IL-1β in constructs cultured for 48 hours
(Figure 3). At 1, 5 and 21% oxygen tension, NO production
was enhanced with FN-f or IL-1β compared to untreated
controls (all P <0.001; Figure 3A). At 5% oxygen tension,
FN-f increased NO production (45 μM) with values signifi-
cantly greater than cytokine-treated (28 μM) constructs
(P <0.001). At all oxygen tensions, co-incubation with
L-NIO reduced fragment or cytokine-induced NO levels
with values returning to basal levels (<5 μM). PGE2 release
was increased with either FN-f or IL-1β at 5 and 21%
oxygen tension (P <0.001) but not at 1% oxygen tension
(Figure 3B). Co-incubation with L-NIO partially reduced
PGE2 levels in FN-f treated constructs cultured at 5 and21% oxygen tension. Furthermore, FN-f reduced GAG
synthesis at 1, 5 and 21% oxygen tension (P <0.001;
Figure 3C). In contrast, the cytokine decreased GAG syn-
thesis at 1% oxygen tension (P <0.01; Figure 3F) but not at
5 or 21% oxygen tension. At 1 or 5% oxygen tension, frag-
ment or cytokine-induced inhibition on GAG synthesis
was reversed with L-NIO (both P <0.05).Compression abolished FN-f induced catabolic effects at 5
and 21% oxygen tension
Since the catabolic effects in response to FN-f were
maximal at 5% oxygen tension, further ex vivo studies ex-
amined the effect of dynamic compression in constructs
cultured at 5 and 21% oxygen tension and compared the
response to IL-1β. Figure 4 reveals that dynamic compres-
sion inhibits NO release at 5 and 21% oxygen tension
(P <0.001; Figure 4A). In unstrained constructs, FN-f en-
hanced NO production (P <0.001) with values highest at
5% oxygen tension when compared to the effects of IL-1β
(P <0.001). The enhanced production of NO by fragment,
cytokine or low oxygen tension was reduced with dy-
namic compression (all P <0.001; Figure 4A). Stimula-
tion with compression and the NOS inhibitor reduced
NO levels further in fragment or cytokine treated con-
structs (all P <0.001; Figure 4A).
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Figure 3 Effect of oxygen tension and FN-f on catabolic and anabolic activities. Chondrocyte/agarose constructs were cultured under
uninterrupted experimental conditions with 0 or 1 μM FN-f or 10 ng/ml IL-1β in the presence or absence of 1 mM L-NIO at 1, 5 and 21% oxygen
tension for 48 hours, where NO release (A), PGE2 production (B) and GAG synthesis (C). Error bars represent the mean and SEM of 12 values from
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PGE2 release in untreated constructs (P <0.001; Figure 4B).
In unstrained constructs, the presence of the fragment
or cytokine enhanced PGE2 release with values broadlysimilar and ranging from 7.6 to 8.0 pg/ml for constructs
cultured at 5 or 21% oxygen tension. Stimulation with
dynamic compression and/or L-NIO reduced PGE2 levels
to basal values in an oxygen-independent manner (all
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Figure 4 Effect of oxygen tension, FN-f and dynamic compression on catabolic and anabolic activities. Chondrocyte/agarose constructs
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between 77 and 87%.
In untreated samples, total MMP activity was inhibited
with dynamic compression at 5% oxygen tension. The
fragment or cytokine increased MMP activity with max-
imal values at 5% oxygen tension for constructs cultured
with FN-f when compared to IL-1β (P <0.001). At 5 or
21% oxygen tension, stimulation with dynamic compres-
sion or the NOS inhibitor abolished fragment or cyto-
kine induced MMP activity (all P <0.001; Figure 4C). In
addition, dynamic compression increased GAG synthesis
(P <0.001; Figure 4D) with a greater magnitude in stimu-
lation for constructs cultured at 21% oxygen tension
(136%) when compared to 5% (79%). At 5 and 21% oxy-
gen tension, the presence of the FN-f or IL-1β reduced
GAG synthesis (all P <0.05; Figure 4D). This response
was reversed by stimulation with dynamic compression
and L-NIO at 5 and 21% oxygen tension.Compression inhibits FN-f induced gene expression at 5
and 21% oxygen tension
The effect of oxygen tension and FN-f on catabolic (iNOS
and COX-2) and anabolic (aggrecan and type II collagen)
gene expression is presented in Figure 5. Treatment with
FN-f increased iNOS and COX-2 expression with a similar
magnitude to IL-1β (all P <0.001; Figure 5A, B, respect-
ively). In unstrained constructs, the effect of hypoxia in-
creased iNOS, aggrecan and collagen type II (all P <0.001),
but not COX-2 expression. At 5 and 21% oxygen tension,
stimulation with dynamic compression alone resulted in a
reduction of iNOS and COX-2 expression in constructs
cultured with FN-f or IL-1β (all P <0.001).
Co-stimulation with compression and L-NIO marginally
reduced iNOS but not COX-2 expression further. Con-
versely, fragment or cytokine treatment decreased aggre-
can expression at 5 and 21% oxygen tension (both P
<0.001; Figure 5C, D, respectively). In addition, the
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Figure 5 Effect of oxygen tension, FN-f and dynamic compression on gene expression. Chondrocyte/agarose constructs were cultured at 5
and 21% oxygen tension with 0 or 1 μM FN-f or 10 ng/ml IL-1β and/or 1 mM LNIO for six hours, where iNOS (A), COX-2 (B), aggrecan (C) and
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tension. All other comparisons were not significant (not indicated).
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http://arthritis-research.com/content/15/5/R163fragment, but not cytokine, reduced collagen type II ex-
pression at 21% oxygen tension (P <0.001; Figure 5D). At
5 and 21% oxygen tension, co-stimulation with compres-
sion and the NOS inhibitor restored aggrecan and colla-
gen type II expression in fragment or cytokine treated
constructs cultured at 5 and 21% oxygen tension.
Compression inhibits FN-f induced cytokine production at
5 and 21% oxygen tension
We next examined the effect of FN-f, compression and
oxygen tension on the production of pro-inflammatory cy-
tokines and compared the response to constructs treated
with exogenous IL-1β (Figure 6). In unstrained constructs,
FN-f significantly increased IL-1β, IL-6 and TNFα produc-
tion to a larger effect than the corresponding increase
with exogenous cytokine treatment (all P <0.001). At 5%oxygen tension, the fragment or cytokine enhanced
greater production of IL-1β and TNFα than at 21% oxygen
tension. In contrast, the effects of fragment or cytokine on
IL-6 production were broadly similar for constructs cul-
tured at 5 and 21% oxygen tension. Cytokine production
was reduced with dynamic compression and/or L-NIO
in an oxygen-independent manner with the magnitude
broadly similar for all treatments.
Discussion
Matrix fragments are known to exert destructive effects
in OA pathophysiology and regulate tissue remodelling
events in chondrocytes [28]. In OA cartilage, exogenous
cytokines increase iNOS expression and NO production
leading to proteoglycan degradation [29,30]. The cata-
bolic environment attempts to assist with tissue
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http://arthritis-research.com/content/15/5/R163remodelling but the response will be influenced by
mechanical factors. The question arises as to whether
mechanical loading could act to slow down tissue dam-
age during the early phase of the disease process or ef-
fectively contribute to OA progression. In addition, thelevels of oxygen tension in the injured joint will have a
significant impact on the metabolic processes thereby af-
fecting the maintenance of fragment-induced pathway.
The interactions among matrix fragments, oxygen tension
and mechanical loading are, therefore, complex, and thus
motivate the current investigation.
At 21% oxygen tension, FN-fs ranging from 29 to
140 kDa have been observed to bind to the pericellular
matrix leading to NO, MMP and cytokine up-regulation,
suppression of matrix synthesis and proteoglycan loss in
a concentration-dependent manner [1,11,12,31-33]. We
reported that the 29 kDa NH2-heparin binding fragment
is highly active and increased NO and PGE2 production in
a 3D/agarose model when compared with other matrix
fragment types [16,25]. However, our previous studies
tested commercially available fragments in contrast to the
present work which generated FN-fs from cathepsin D
and thrombin digests isolated from human plasma fibro-
nectin, as previously described [24]. Our data are in agree-
ment with previous findings, demonstrating a greater
production of NO and PGE2 with FN-f when compared to
IL-1β treatment and the response was reduced with NOS
inhibitors. Interestingly, the fragment-induced catabolic
response was greater at 5% when compared to 1 or 21%
oxygen tension and resulted in an associated inhibition of
matrix synthesis that was broadly similar at all oxygen ten-
sions examined. However, we were unable to detect PGE2
synthesis in constructs cultured with fragment or cytokine
under severe hypoxia (1%) conditions. Since prostaglandin
synthesis involves the oxygenation of arachidonic acid into
intermediates that are oxidised by COX leading to PGE2
synthesis, the oxygen concentration dependent effects will
slow down production of inflammatory mediators. A simi-
lar response was reported in bovine chondrocytes treated
with IL-1β in suspension culture, with a more pronounced
increase of NO and PGE2 production at 5% when com-
pared to 1 or 21% oxygen tension [34]. The effect of FN-fs
and oxygen tension has not been previously investigated in
chondrocytes. This is the first study to show that the
fragment-induced catabolic effects are oxygen-sensitive and
amplified under hypoxic conditions. Furthermore, studies
on the effect of oxygen tension on the inflammatory re-
sponse in chondrocytes have resulted in conflicting out-
comes. Normoxia (20%) conditions were observed to
produce greater levels of NO and PGE2 production in cyto-
kine (IL-1α or TNFα) treated porcine explants when com-
pared to severe hypoxia (1%) [35]. In contrast, moderate
hypoxia (6%) reduced oxidative stress, stabilise hypoxia-
inducible factor-1α (HIF-1α) expression and lowered
MMP-9 levels in cytokine-induced chondrocytes compared
to normoxia (21%) [36]. In OA chondrocytes, HIF-1α
over-expression is known to be detrimental to cartilage
physiology and its regulation by oxygen tension may
present a potential therapeutic target for treating OA. In
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Figure 7 Summary of interactions between FN-f, oxygen tension and biomechanical signals. The presence of FN-f combined with low
oxygen tension amplifies catabolic activities and increased production of NO, PGE2, MMPs and cytokines. Catabolic activities were reduced with
L-NIO. However, the response was abolished following stimulation with biomechanical signals alone leading to restoration of anabolic effects.
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http://arthritis-research.com/content/15/5/R163addition, the cytokine-induced production of NO at 5%
oxygen tension was mediated by factors involved in the
MAPK and NFκβ pathways, highlighting additional
oxygen-sensitive mediators as potential targets for OA
therapy [34,37,38]. Taken together, these studies empha-
sise the oxygen-dependency of the inflammatory response
and suggest that further studies should examine the inter-
play of fragment and cytokine-induced pathways with oxy-
gen tension.
The effect of FN-fs and mechanical loading are sum-
marised in Figure 7. Whilst NOS inhibitors reduced FN-
f induced catabolic activities in unstrained constructs,
treatment with L-NIO alone did not restore matrix syn-
thesis (Figure 7A). In contrast, the loading-induced re-
sponse was found to be oxygen-independent, such that
stimulation with dynamic compression alone blocked
fragment-induced catabolic effects at 5 or 21% oxygen
tension (Figure 7B). Furthermore, the beneficial response
associated with anabolic activities was supported by en-
hanced matrix synthesis and gene expression of aggrecan
and collagen type II. This is the first report to show the
combined effects of oxygen tension and dynamic com-
pression on the suppression of fragment-induced cata-
bolic events in an ex vivo model. It is well recognised
that mechanical loading combined with oxygen tension
will influence the production of inflammatory mediators.Indeed, in the absence of exogenous factors, mechanical
compression increased NO production at 5 and 20%
oxygen tension and the loading-induced catabolic re-
sponse was reduced at 1% in porcine cartilage explants
[21]. In contrast, long-term mechanical stimulation at 5%
oxygen tension increased matrix synthesis and stabilised
chondrogenic gene expression when compared to nor-
moxic conditions (21%) in a chondrocyte/polyurethane
model [39]. Conversely, cyclic stretch was reported to in-
crease IL-8 and TNFα production in macrophages and the
response was independent of oxygen tension [40]. How-
ever, it is not entirely known how biomechanical signals
combined with oxygen tension influence the inflammatory
pathways induced by fragments or cytokines. Indeed, at
normoxic conditions, there is strong evidence which im-
plicates the α5β1 integrin as a receptor for both mechan-
ical loading and matrix fragments implicating overlapping
pathways for these signals [41,42]. Integrin-mediated
mechanotransduction will contribute to chondroprotec-
tive events resulting in an attempt by cells to stimulate
anabolic processes locally and assist in tissue remodelling.
However, conditions such as obesity or trauma that repre-
sent excessive or injurious loading will increase catabolic
activities and accelerate matrix damage mediated by ab-
normal integrin signals [43,44]. Integrins serve as recep-
tors for several matrix proteins involving the collagens
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http://arthritis-research.com/content/15/5/R163and fibronectin. There may be shared ability among
matrix fragments to disrupt integrin receptors at the cell
surface and enhance receptor internalisation, thereby pre-
venting integrin cluster formation and adhesion with
matrix proteins. The disruption in normal interactions
and changes in oxygen tension will influence matrix turn-
over, which, in turn, affects the ability of the tissue to re-
spond to normal mechanical signals. It is not known
whether oxygen tensions which exist in a diseased state
(<5%) will aggravate mechanical and fragment-induced in-
tegrin signals and this should be explored further.
In free-swelling or unstrained constructs, the present
study demonstrates for the first time that exogenous
FN-f combined with low oxygen tension amplifies
the production of catabolic mediators in an oxygen-
dependent manner. In unstrained constructs, the cata-
bolic effects were reduced with NOS inhibitors and
abolished following stimulation with biomechanical sig-
nals alone. Both types of stimuli blocked the damaging
effects induced by matrix fragments and restored ana-
bolic activities in an oxygen-independent manner. Since
FN-fs share the same receptors as mechanical loading,
the effect of oxygen tension on integrin signals should
be explored to identify whether integrin agonists or frag-
ment oxygen-sensitive antagonists could be developed
with ex vivo physio-biomimetic models. In addition, the
mechanical environment clearly influences both repara-
tive and tissue remodelling events in vivo, thereby
emphasising the need to dissect the effects induced by
fragments, oxygen tension and biomechanical signals.
This knowledge could lead to the development of novel
therapeutics for OA treatments.
Conclusions
The 29 kDa NH2-FN-f is highly active and triggers the
most damage ex vivo. The importance of fragment-
induced damaging effects was highlighted in previous
clinical studies which reported enhanced levels of FN-fs
in human osteoarthritic cartilage and OA synovial fluids.
Future therapeutics should, therefore, develop oxygen-
sensitive molecular antagonists which are directed to
specific domains of fibronectin. This could either pre-
vent the generation of matrix fragments through anti-
protease therapy or neutralise the effects of fragments
by targeting multiple integrins. In addition, development
of ex vivo physio-biomimetic models may help to exam-
ine the effect of an integrin agonist that maintains
normal cell surface interactions with the extracellular
matrix. Since physiological biomechanical signals are
anti-inflammatory, this approach will facilitate develop-
ment of therapeutics which slow down inflammation
and allow the protective effects of moderate exercise or
physiotherapy, to repair tissue and restore joint function
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